FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of January, 2003
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Technical Interest in Shares released 13 January, 2003
NOTIFICATION TO STOCK EXCHANGE
13th January 2003
To: Announcements Office
The London Stock Exchange
From: Celltech Group plc
208 Bath Road
Slough
Berkshire
SL1 3WE
Dear Sirs
CELLTECH GROUP EMPLOYEE SHARE TRUST ("Trust")
Dr Fellner, Mr Allen and Dr Lee (together the "Directors").
Notification of Director's interests pursuant to section 324(2) of the Companies Act 1985.
The Company became aware on 13th January 2003 that each of the Directors technically became interested on 13th January 2003 in 400,000 ordinary shares of 50p each in the Company by virtue of the Trust acquiring such shares for the Celltech Deferred Bonus Plan and the Directors being potential beneficiaries under the Trust.
Yours faithfully
J A D Slater
Company Secretary
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH GROUP PLC
(Registrant)
By: /s/ PETER ALLEN
Peter Allen
Chief Financial Officer
Dated: 13 January, 2003